Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/24/2021 7 2
Lurasidone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 2 0
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Ascorbic acid Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021 2 0
Resveratrol Potential treatment - pre-clinical evidence Natural product Antiviral Feb/23/2021 2 0
Glucocorticoids Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/06/2021 5 0